ImmuneOnco Biopharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Deals

12 September 2024

One ricochet of the ivonescimab bullet

The small cap biotech Instil Bio tries to follow in Summit’s slipstream.

Subscribe to ImmuneOnco Biopharmaceuticals